Nautilus Biotechnolgy, Inc. NAUT 深 沪
等待开盘 05-19 09:30:00 美东时间
2.36
-0.150
-5.98%
华盛通- 最 高2.59
- 今 开2.53
- 成交量 56.27万股
- 最 低 2.35
- 昨 收 2.51
- 总市值 3.00亿
- 52周最高 4.3101
- 市盈率 静 --
- 换手率 0.44%
- 52周最低 0.62
- 委 比 70.21%
- 总股本 1.27亿
- 历史最高 12.38
- 量 比 0.98
- 振 幅 9.56%
- 历史最低 0.62
- 每 手 1
- 风险率 0.90%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nautilus Biotechnology Reports Q1 2026 Results: Full Earnings Call Transcript
Nautilus Biotechnology (NASDAQ:NAUT) reported first-quarter financial results o...
04-28 21:20
Earnings Scheduled For April 28, 2026
Companies Reporting Before The Bell • LGI Homes (NASDAQ:LGIH) is likely to repo...
04-28 19:11
Nautilus Biotechnology Q1 EPS $(0.12) Beats $(0.17) Estimate
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.17) by 25 percent. This is a 7.69 percent increase over losses of $(0.13) per share
04-28 18:11
Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures lower on Thursday with Applied Digital Corp. (APLD) falling sharply in pre-market trading after beating analyst estimates.
04-09 20:08
美股大行评级 | 下调居多！多邻国、Elastic、Flutter、欧特克、Zscaler等遭多家机构下调目标价
今日重点评级关注：巴克莱：维持C4 Therapeutics"超配"评级，目标价从5美元升至7美元；富国银行：维持Agilon Health"超配"评级，目标价从1美元升至1.5美元
03-02 14:08
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Curanex Pharmaceuticals (NASDAQ:CURX) shares moved upwards by 57.7% to...
02-27 01:05
Nautilus Biotechnology Q4 EPS $(0.11) Beats $(0.14) Estimate
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 21.43 percent increase over losses of $(0.14) per share
02-26 19:11
Nautilus Biotechnology Debuts Voyager Platform To Power Iterative Mapping Of Up To 10B Intact Proteins And Proteoforms Simultaneously In Single Run
Nautilus Biotechnology, Inc. (NASDAQ:NAUT), a company pioneering single-molecule proteome analysis, today debuted the Voyager™ Platform, which is designed to power the Iterative Mapping of up to 10 billion intact
02-24 21:07
Nautilus Biotechnology, Weill Cornell Medicine-Qatar And Michael J. Fox Foundation Collaborate To Study Connection Between Alpha-Synuclein Protein And Parkinson's Disease
Support from The Michael J. Fox Foundation for Parkinson's Research to advance critical research into Parkinson's disease biology • Nautilus' development of a single-molecule assay for measuring alpha-synuclein
01-28 21:03
